November 24, 2008
SpeculatingStocks.com Stock Pick: Matrixx Initiatives, Inc. (MTXX)
Stock Price: $14.77
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize the company's drug delivery systems. Its wholly-owned subsidiary, Zicam, LLC, markets and sells Zicam® and Nasal Comfort(TM) products in the cough and cold category.
MTXX also offers Zicam Multi-Symptom Cold and Flu Relief products, which utilize a spoon dosing delivery to provide relief of cold and flu symptoms.
MTXX is a perennial cold and flu season stock play and well known for that fact. MTXX dropped the last four trading days creating a buying opportunity to play this year's cold and flu season.
MTXX's over-the-counter cold and flu products are sold at several large national retailers including Wal-Mart, Walgreens, and CVS. Zicam is one of the top three cough, cold and allergy growth brands and its multi-symptom cold and flu products account for 45% of the company's retail sales growth.
MTXX has a attractive brand and sold distribution network in place. We believe MTXX will have another cold and flu season move.